The Latest Breaking News on Pharma

For the first time in a decade, Americans will pay less next year on monthly premiums for Medicare’s Part B plan, which covers routine doctors’ visits and other outpatient care

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors in the form of speakers and consulting fees to persuade them to prescribe its multiple sclerosis drugs

The biotech industry witnessed solid growth during the pandemic. However, that seems to be fading away amid the receding pandemic and growing recession concerns. So, it could be wise to avoid biotech stocks Ginkgo Bioworks Holdings (DNA), GeoVax Labs (GOVX), and Aditxt (ADTX), given their bleak fundamentals. Read on….

Record-high inflation, the Federal Reserve's hawkish stance, and growing recession fears have increased market volatility. Nevertheless, despite the unsettling macroenvironment, few stocks have delivered stable returns and could continue to beat the market based on their solid growth attributes. AbbVie Inc. (ABBV), J. Jill Inc. (JILL), and Bassett Furniture Industries…

The new chief at the Food and Drug Administration's tobacco center has inherited a raft of problems

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11

Carvedilol could be the poster child for how to lower drug prices. Since 2007, more than 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which cost 2 cents a dose compared with $4.81 for the brand-name product. Patents on the drug Coreg, dating back…

Many pharmacies and physicians are forced to deny patients access to drugs, such as methotrexate, that can be used to help induce an abortion